112 results match your criteria: "Beth Israel Deaconess Medical Center Harvard Medical School Boston[Affiliation]"
Background: Physicians and trainees in academic health care settings face unique challenges to maintaining and enhancing their well-being compared to their community practice counterparts.
Objective: Our objective was to develop a research agenda focused on well-being, resilience, and career longevity issues specific to practicing emergency medicine in an academic setting.
Methods: We convened an expert group of academic emergency physicians prior to the 2018 annual meeting of the Society for Academic Emergency Medicine to determine a set of uniformly accepted research priorities in the field by consensus.
Mov Disord Clin Pract
October 2018
The Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, Division of Neurology University of Toronto Toronto Canada.
Background: The Fahn-Tolosa-Marin Clinical Rating Scale for Tremor (FTM) has been used in large trials for essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too low for patients with severe tremor (tremor amplitude >4 cm; grade 4). The Essential Tremor Rating Assessment Scale (TETRAS) is a validated clinical scale designed specifically for the assessment of ET severity. TETRAS has anchors that span a larger range of tremor amplitudes (>20 cm = grade 4), making it more suitable for assessing patients with severe ET.
View Article and Find Full Text PDFRes Pract Thromb Haemost
October 2018
Background: The management of anticoagulation for cancer-associated thrombosis (CAT) in patients with thrombocytopenia is controversial. Whereas some studies suggest that administration of reduced-dose low-molecular-weight heparin (LMWH) or temporary discontinuation for moderate and severe thrombocytopenia may be a safe and effective, others suggest full-dose anticoagulation with transfusion support. We sought to address this important knowledge gap and summarize the literature comparing these two common management strategies.
View Article and Find Full Text PDFReg Anesth Pain Med
August 2018
Department of Anesthesia Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA Department of Anesthesiology Perioperative and Pain Medicine Brigham and Women's Hospital Harvard Medical School Boston, MA Department of Anesthesiology Perioperative and Pain Medicine Brigham and Women's Hospital Harvard Medical School and Center for Perioperative Research Brigham and Women's Hospital Boston, MA.
Acute Med Surg
January 2018
Background And Purpose: The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016), a Japanese-specific set of clinical practice guidelines for sepsis and septic shock created jointly by the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine, was first released in February 2017 in Japanese. An English-language version of these guidelines was created based on the contents of the original Japanese-language version.
Methods: Members of the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine were selected and organized into 19 committee members and 52 working group members.
Bioeng Transl Med
January 2018
DNA damaging chemotherapy is a cornerstone of current front-line treatments for advanced ovarian cancer (OC). Despite the fact that a majority of these patients initially respond to therapy, most will relapse with chemo-resistant disease; therefore, adjuvant treatments that synergize with DNA-damaging chemotherapy could improve treatment outcomes and survival in patients with this deadly disease. Here, we report the development of a nanoscale peptide-nucleic acid complex that facilitates tumor-specific RNA interference therapy to chemosensitize advanced ovarian tumors to frontline platinum/taxane therapy.
View Article and Find Full Text PDFESC Heart Fail
February 2017
Program in Cardio-oncology, Department of Internal Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center Harvard Medical School Boston MA USA.
Gemcitabine is a commonly used antineoplastic agent used to treat a variety of cancers with rarely reported cardiac side effects. We describe a case of a 67-year-old woman with follicular lymphoma who experienced a rarely reported side effect of gemcitabine: cardiomyopathy. This case highlights a multiple hit mechanism of myocyte damage that may occur following the use of multiple cardio-toxic agents despite their administration in doses not associated with cardiotoxicity.
View Article and Find Full Text PDFJ Cardiothorac Vasc Anesth
June 2017
Department of Anesthesia, Critical Care, and Pain Medicine Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA.
J Cardiothorac Vasc Anesth
April 2017
Department of Anesthesia, Critical Care, and Pain Medicine Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA.
J Cardiothorac Vasc Anesth
February 2017
Department of Anesthesia, Critical Care, and Pain Medicine Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA.
We investigated delay in diagnosing progressive multifocal leukoencephalopathy (PML). The median time from initial symptom to diagnosis was 74 days (range 1-1643) in 111 PML patients seen at our institution from 1993 to 2015. Another diagnosis was considered before PML in nearly two-thirds, and more than three-quarters of patients suffered from diagnostic delay greater than 1 month, irrespective of their underlying immunosuppressive condition.
View Article and Find Full Text PDFJ Bronchology Interv Pulmonol
April 2016
*Division of Thoracic Surgery and Interventional Pulmonology Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA †Interventional Pulmonology Clinica Alemana-Universidad Del Desarrollo, Santiago, Chile.
J ECT
September 2016
Brigham and Women's Hospital Harvard Medical School Boston, MA Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA.
J Cardiothorac Vasc Anesth
January 2016
Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA.
Am J Respir Crit Care Med
February 2016
4 Faculty of Health Sciences Simon Fraser University Burnaby, British Columbia, Canada.
Background: Several clinical studies have indicated that selective serotonin reuptake inhibitors (SSRIs) administered in patients after acute ischemic stroke can improve clinical recovery independently of depression. Due to small sample sizes and heterogeneous study designs interpretability was limited in these studies. The mechanisms of action whereby SSRI might improve recovery from acute ischemic stroke are not fully elucidated.
View Article and Find Full Text PDFDermatol Surg
October 2015
Department of Medicine Beth Israel Deaconess Medical Center Harvard Medical School Boston, Massachusetts Department of Dermatology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
J Cardiothorac Vasc Anesth
October 2015
Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA.
Clin Ther
April 2015
Division of Oncology, Beth Israel Deaconess Medical Center Harvard Medical School Boston, Massachusetts.
Front Microbiol
December 2014
Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center - Harvard Medical School Boston, MA, USA.
Hepatitis C virus (HCV) infection has become a global public health burden costing billions of dollars in health care annually. Even with rapidly advancing scientific technologies this disease still poses a significant threat due to a lack of vaccines and affordable treatment options. The immune correlates of protection and predisposing factors toward chronicity remain major obstacles to development of HCV vaccines and immunotherapeutics due, at least in part, to lack of a tangible infection animal model.
View Article and Find Full Text PDFFront Hum Neurosci
August 2014
Department of Neurology, Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center - Harvard Medical School Boston, MA, USA ; Neuromodulation Program and Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital - Harvard Medical School Boston, MA, USA.
The developmental pathophysiology of autism spectrum disorders (ASD) is currently not fully understood. However, multiple lines of evidence suggest that the behavioral phenotype may result from dysfunctional inhibitory control over excitatory synaptic plasticity. Consistent with this claim, previous studies indicate that adults with Asperger's Syndrome show an abnormally extended modulation of corticospinal excitability following a train of repetitive transcranial magnetic stimulation (rTMS).
View Article and Find Full Text PDF